Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects
PHASE2
A randomized, double-blind, placebo-controlled, dose-ranging study to exami...
Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
PHASE2
Study DFA102E is an extension of Study DFA102, which included a 28-week tre...